Diagnostic tests for tubal pathology from a clinical and economic perspective Verhoeve, H.R.

Transcriptie

1 UvA-DARE (Digital Academic Repository) Diagnostic tests for tubal pathology from a clinical and economic perspective Verhoeve, H.R. Link to publication Citation for published version (APA): Verhoeve, H. R. (2013). Diagnostic tests for tubal pathology from a clinical and economic perspective General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please send a message to: UBAcoach or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam ( Download date: 26 dec. 2016

2 ADDENDUM List of publications Wondergem J, van der Laarse A, van Ravels FJ, van Wermeskerken AM, Verhoeve HR, de Graaf BW, Leer JW. In-vitro assessment of cardiac performance after irradiation using an isolated rat heart preparation. Int J Radiat Biol 1991, 59(4): Steures P,van der Steeg JW, Mol BW, Eijkemans MJ, van der Veen F, Habbema JD, Hompes PG, Bossuyt PM, Verhoeve HR, van Kasteren YM, van Dop PA; CECERM (Collaborative Effort in Clinical Evaluation in Reproductive Medicine). Prediction of an ongoing pregnancy after intrauterine insemination. Fertil Steril 2004, 82(1): Mochtar MH, Bernardus RE, Hamilton CJCM, van Krevel H, Leerentveld B, van Kasteren YM, Wiegerinck MAHM, Flierman PA, Verhoeve HR, van der Veen F. The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF/ICSI. Hum Reprod 2004, 19(8): Steures P, van der Steeg JW, Verhoeve HR, van Dop PA, Hompes PG, Bossuyt PM, van der Veen F, Habbema JD, Eijkemans MJ, Mol BW. Does ovarian hyperstimulation in intrauterine insemination for cervical factor subfertility improve pregnancy rates? Hum Reprod 2004, 19(10): van Leeuwen E, de Vries JWA, Jurriaans S, Verhoeve HR, Prins JM, Repping S en van der Veen F. Intra-uterine inseminatie met bewerkt sperma bij HIV-serodiscordante paren met een HIV-positieve man. Ned Tijdschr Geneeskd 2005, 149: Verhoeve HR, van der Veen F, Mol BW. Diagnostic tests in reproductive medicine. Reviews in Gynaecological and Perinatal Practice 2006, 6:20-25* Steures P, van der Steeg JW, Hompes PG, Habbema JDF, Eijkemans MJ, Broekmans FJ, Verhoeve HR, Bossuyt PM, van der Veen F, Mol BW. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial. The Lancet 2006, 368: Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, Vogel NE, Arts EG, de Vries JW, Bossuyt PM, Buys CH, Heineman MJ,Repping S, van der Veen F. In vitro fertilization with preimplantation genetic screening. N. Engl. J. Med. 2007, 357(1):9-17 Coppus SFPJ, Verhoeve HR, Opmeer BC, van der Steeg JW, Steures P, Eijkemans MJC, Hompes PGA, Bossuyt PMM, van der Veen F, Mol BWJ. Identifying subfertile ovulatory women for timely tubal patency testing: a clinical decision rule. Human Reprod 2007, 22(10): *. 158

3 LIST OF PUBLICATIONS Verhoeve HR, Steures P, Flierman PA, van der Veen F, Mol BWJ. History of induced abortion and the risk of tubal pathology. Reprod Biomed Online 2008, 16(2):304-7*. van Mello NM, Mol F, Adriaanse AH, Boss EA, Dijkman AB, Doornbos JP, Emanuel MH, Friederich J, van der Leeuw-Harmsen L, Lips JP, van Santbrink EJ, Verhoeve HR, Visser H, Ankum WM, van der Veen F, Mol BW, Hajenius PJ. The METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial. BMC Womens Health 2008, 8(1):10. Mol F, Strandell A, Jurkovic D, Yalcinkaya T, Verhoeve HR, Koks CA, van der Linden PJ, Graziosi GC, Thurkow AL, Hoek A, Hogström L, Klinte I, Nilsson K, van Mello NM, Ankum WM, van der Veen F, Mol BW, Hajenius PJ; European Surgery in Ectopic Pregnancy study group. The ESEP study: salpingostomy versus salpingectomy for tubal ectopic pregnancy; the impact on future fertility: a randomised controlled trial. BMC Womens Health 2008, 8:11 Steures P, van der Steeg JW, Hompes PGA, Bossuyt PMM, van der Veen F, Habbema JDF, Eijkemans MJC, Broekmans FJ, Verhoeve HR en Mol BWJ; Intra-uteriene inseminatie met gecontroleerde ovariële hyperstimulatie vergeleken met een afwachtend beleid bij paren met onverklaarde subfertiliteit en een gemiddelde prognose: een gerandomiseerd onderzoek. Ned Tijdschr Geneeskd 2008, 152: Kuipers RS, van der Akker ASA, Erwich JJHM, Verhoeve HR, Torrenga B, Blaauwgeers JLG. Een ectopische zwangerschap? Tijdschrift voor Verloskundigen 2008, 33(11): Luttjeboer FY, Verhoeve HR, van Dessel HJ, van der Veen F, Mol BWJ, Coppus SFPJ. The value of medical history taking in diagnosing tubal pathology: a systematic review. BJOG 2009, 116(5):612-25*. Bensdorp AJ, Slappendel E, Koks CAM, Oosterhuis J, Hoek A, Hompes PGA, Broekmans FJ, Verhoeve HR, de Bruin JP, van Weert JM, Traas M, Maas J, Beckers N, Repping S, Mol BW, van der Veen F, van Wely M. The INeS study: prevention of multiple pregnancies: a randomised controlled trial comparing IUI COH versus IVF e SET versus MNC IVF in couples with unexplained or mild male subfertility. BMC Womens Health 2009, 9:35. Kaandorp SP, Goddijn M, van der Post JAM, Hutten BA, Verhoeve HR, Hamulyak K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DNM, Buller HR, van der Veen F, Middeldorp S. Aspirin combined with low-molecular-weight heparin and aspirin alone in women with recurrent miscarriage. A randomized placebo-controlled trial: the ALIFE study. N. Engl. J. Med. 2010, 362(17):

4 ADDENDUM de Melker AA, Verhoeve HR, Goddijn M, van der Veen F, Repping S. Stand van zaken. Voortplanting met behulp van gevitrificeerde oöcyten. Ned Tijdschr Geneeskd 2010, 154:A1715. Verhoeve HR, Coppus SFPM, van der Steeg JW, Steures P, Hompes PGA, Bourdrez P, Bossuyt PMM, van der Veen F, Mol BWJ for CECERM: The capacity of HSG and laparoscopy to predict natural conception. Hum Reprod 2011, 26(1):134-42*. Kaandorp SP, Goddijn M, van der Post JAM, Hutten BA, Verhoeve HR, Hamulyàk K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DNM, Büller HR, van der Veen F, Middeldorp S. De ALIFE studie: Aspirine en heparine of alleen aspirine bij vrouwen met herhaalde miskraam. NTOG 2011, 124(2): Mol F, van den Boogaard E, van Mello NM, van der Veen F, Mol BW, Ankum WM, van Zonneveld P, Dijkman AB, Verhoeve HR, Mozes A, Goddijn M, Hajenius PJ. Guideline adherence in the management of ectopic pregnancy: room for improvement. Hum Reprod 2011, 26(2): Mochtar MH, Custers IM, Koks CAM, Bernardus RE, Verhoeve HR, Mol BW, van Wely M, van der Veen F. Timing oocyte collection in GnRH agonists down-regulated IVF and ICSI cycles: a randomized clinical trial. Hum Reprod 2011, 26(5): van den Boogaard E, Hermens RPMG, Verhoeve HR., Kremer JAM, van der Veen F, Knegt AC, Goddijn M. Selective karyotyping in recurrent miscarriage: is recent evidence adopted in daily clinical practice? Hum Reprod 2011, 26(8): Broek RPG ten, Kok-Krant N, Verhoeve HR, van Goor H, Bakkum EA. Efficacy of Polyethylene Glycol Adhesion Barrier After Gynecological Laparoscopic Surgery; Results of a Randomized Controlled Pilot Study. Gynecological Surgery 2012, 9(1): Verhoeve HR, Moolenaar LM, Hompes PGA, van der Veen F, Mol BWJ: Kosteneffectiviteit van tubatesten. NTOG 2012, 127(3): van Tilborg TC, Eijkemans MJ, Laven JS, Koks CA, de Bruin JP, Scheffer GJ, van Golde RJ, Fleischer K, Hoek A, Nap AW, Kuchenbecker WKh, Manger PA, Brinkhuis EA, van Heusden AM, Sluijmer AV, Verhoeff A, van Hooff MH, Friederich J, Smeenk JM, Kwee J, Verhoeve HR, Lambalk CB, Helmerhorst FM, van der Veen F, Mol BW, Torrance HL, Broekmans FJ. The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial. BMC Womens Health 2012, 12:

5 LIST OF PUBLICATIONS van Mello NM, Mol F, Verhoeve HR, van Wely M, Adriaanse AH, Boss EA, Dijkman AB, Bayram N, Emanuel MH, Friederich J, van der Leeuw-Harmsen L, Lips JP, Van Kessel MA, Ankum WM, van der Veen F, Mol BW, Hajenius PJ. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hcg concentrations? A randomized comparison. Hum Reprod 2013, 28(1):60-7. Verhoeve HR, Moolenaar LM, van der Veen F, Hompes PGA, Mol BW. Cost-effectiveness of tubal patency tests. BJOG 2012, accepted for publication, BJOG 2013 in press.* Boeken Mol BW, Van der Steeg JW, Verhoeve HR, Van der Veen F. How to conceive: evidence-based fertility investigation. Macklon, Greer & Steegers (eds). Textbook of Periconceptional Medicine. Informa healthcare. London * Presented in this thesis 161